 | • レポートコード：MRC2-11QY01435 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はヒトロタウイルスワクチンのグローバル市場について調査・分析したレポートです。種類別（Rotarix、RotaTeq、Rotavac、Rotavin-M1、蘭州ラム、その他）市場規模、用途別（病院・診療所、学術・研究、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ヒトロタウイルスワクチンの競争状況、市場シェア ・世界のヒトロタウイルスワクチン市場：種類別市場規模 2015年-2020年（Rotarix、RotaTeq、Rotavac、Rotavin-M1、蘭州ラム、その他） ・世界のヒトロタウイルスワクチン市場：種類別市場規模予測 2021年-2026年（Rotarix、RotaTeq、Rotavac、Rotavin-M1、蘭州ラム、その他） ・世界のヒトロタウイルスワクチン市場：用途別市場規模 2015年-2020年（病院・診療所、学術・研究、その他） ・世界のヒトロタウイルスワクチン市場：用途別市場規模予測 2021年-2026年（病院・診療所、学術・研究、その他） ・北米のヒトロタウイルスワクチン市場分析：米国、カナダ ・ヨーロッパのヒトロタウイルスワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのヒトロタウイルスワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のヒトロタウイルスワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのヒトロタウイルスワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bharat Biotech、Merck、GlaxoSmithKline ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease.
Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. The vaccine first became available in the United States in 2006.
Market Analysis and Insights: Global Human Rotavirus Vaccine Market
The global Human Rotavirus Vaccine market size is projected to reach US$ 7209.2 million by 2026, from US$ 6753.8 million in 2020, at a CAGR of 6.2%% during 2021-2026.
Global Human Rotavirus Vaccine Scope and Market Size
Human Rotavirus Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Rotavirus Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Human Rotavirus Vaccine market is segmented into
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Segment by Application, the Human Rotavirus Vaccine market is segmented into
Hospitals & Clinics
Academic And Research
Others
Regional and Country-level Analysis
The Human Rotavirus Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Rotavirus Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Rotavirus Vaccine Market Share Analysis
Human Rotavirus Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Rotavirus Vaccine business, the date to enter into the Human Rotavirus Vaccine market, Human Rotavirus Vaccine product introduction, recent developments, etc.
The major vendors covered:
Bharat Biotech
Merck
GlaxoSmithKline
…
1 Study Coverage
1.1 Human Rotavirus Vaccine Product Introduction
1.2 Market Segments
1.3 Key Human Rotavirus Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Rotavirus Vaccine Market Size Growth Rate by Type
1.4.2 Rotarix
1.4.3 RotaTeq
1.4.4 Rotavac
1.4.5 Rotavin-M1
1.4.6 Lanzhou lamb
1.4.7 Others
1.5 Market by Application
1.5.1 Global Human Rotavirus Vaccine Market Size Growth Rate by Application
1.5.2 Hospitals & Clinics
1.5.3 Academic And Research
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Rotavirus Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Human Rotavirus Vaccine Revenue 2015-2026
2.1.2 Global Human Rotavirus Vaccine Sales 2015-2026
2.2 Global Human Rotavirus Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Human Rotavirus Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Rotavirus Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human Rotavirus Vaccine Competitor Landscape by Players
3.1 Human Rotavirus Vaccine Sales by Manufacturers
3.1.1 Human Rotavirus Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Human Rotavirus Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Human Rotavirus Vaccine Revenue by Manufacturers
3.2.1 Human Rotavirus Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Human Rotavirus Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Rotavirus Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Rotavirus Vaccine Revenue in 2019
3.2.5 Global Human Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Rotavirus Vaccine Price by Manufacturers
3.4 Human Rotavirus Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Human Rotavirus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Rotavirus Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Human Rotavirus Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Rotavirus Vaccine Market Size by Type (2015-2020)
4.1.1 Global Human Rotavirus Vaccine Sales by Type (2015-2020)
4.1.2 Global Human Rotavirus Vaccine Revenue by Type (2015-2020)
4.1.3 Human Rotavirus Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Rotavirus Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Rotavirus Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Human Rotavirus Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Human Rotavirus Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Rotavirus Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Human Rotavirus Vaccine Market Size by Application (2015-2020)
5.1.1 Global Human Rotavirus Vaccine Sales by Application (2015-2020)
5.1.2 Global Human Rotavirus Vaccine Revenue by Application (2015-2020)
5.1.3 Human Rotavirus Vaccine Price by Application (2015-2020)
5.2 Human Rotavirus Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Rotavirus Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Human Rotavirus Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Rotavirus Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Human Rotavirus Vaccine by Country
6.1.1 North America Human Rotavirus Vaccine Sales by Country
6.1.2 North America Human Rotavirus Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Rotavirus Vaccine Market Facts & Figures by Type
6.3 North America Human Rotavirus Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Human Rotavirus Vaccine by Country
7.1.1 Europe Human Rotavirus Vaccine Sales by Country
7.1.2 Europe Human Rotavirus Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Rotavirus Vaccine Market Facts & Figures by Type
7.3 Europe Human Rotavirus Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Human Rotavirus Vaccine by Region
8.1.1 Asia Pacific Human Rotavirus Vaccine Sales by Region
8.1.2 Asia Pacific Human Rotavirus Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Rotavirus Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Human Rotavirus Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Human Rotavirus Vaccine by Country
9.1.1 Latin America Human Rotavirus Vaccine Sales by Country
9.1.2 Latin America Human Rotavirus Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Rotavirus Vaccine Market Facts & Figures by Type
9.3 Central & South America Human Rotavirus Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Human Rotavirus Vaccine by Country
10.1.1 Middle East and Africa Human Rotavirus Vaccine Sales by Country
10.1.2 Middle East and Africa Human Rotavirus Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Rotavirus Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Human Rotavirus Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 Bharat Biotech
11.1.1 Bharat Biotech Corporation Information
11.1.2 Bharat Biotech Description and Business Overview
11.1.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bharat Biotech Human Rotavirus Vaccine Products Offered
11.1.5 Bharat Biotech Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Human Rotavirus Vaccine Products Offered
11.2.5 Merck Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Human Rotavirus Vaccine Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.1 Bharat Biotech
11.1.1 Bharat Biotech Corporation Information
11.1.2 Bharat Biotech Description and Business Overview
11.1.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bharat Biotech Human Rotavirus Vaccine Products Offered
11.1.5 Bharat Biotech Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Rotavirus Vaccine Market Estimates and Projections by Region
12.1.1 Global Human Rotavirus Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Human Rotavirus Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Human Rotavirus Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Human Rotavirus Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Human Rotavirus Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Human Rotavirus Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Human Rotavirus Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Human Rotavirus Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Human Rotavirus Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Human Rotavirus Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Rotavirus Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Rotavirus Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Rotavirus Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Rotavirus Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Rotavirus Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Rotavirus Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Human Rotavirus Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Rotavirus Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Rotavirus Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Rotavirus Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Rotavirus Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Rotavirus Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Human Rotavirus Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Rotavirus Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Human Rotavirus Vaccine Market Segments
Table 2. Ranking of Global Top Human Rotavirus Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Rotavirus Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Rotarix
Table 5. Major Manufacturers of RotaTeq
Table 6. Major Manufacturers of Rotavac
Table 7. Major Manufacturers of Rotavin-M1
Table 8. Major Manufacturers of Lanzhou lamb
Table 9. Major Manufacturers of Others
Table 10. Global Human Rotavirus Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Human Rotavirus Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Human Rotavirus Vaccine Sales by Regions 2015-2020 (K Units)
Table 13. Global Human Rotavirus Vaccine Sales Market Share by Regions (2015-2020)
Table 14. Global Human Rotavirus Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Human Rotavirus Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global Human Rotavirus Vaccine Sales Share by Manufacturers (2015-2020)
Table 17. Global Human Rotavirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Human Rotavirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Rotavirus Vaccine as of 2019)
Table 19. Human Rotavirus Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Human Rotavirus Vaccine Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Human Rotavirus Vaccine Price (2015-2020) (USD/Unit)
Table 22. Human Rotavirus Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Human Rotavirus Vaccine Product Type
Table 24. Date of International Manufacturers Enter into Human Rotavirus Vaccine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Human Rotavirus Vaccine Sales by Type (2015-2020) (K Units)
Table 27. Global Human Rotavirus Vaccine Sales Share by Type (2015-2020)
Table 28. Global Human Rotavirus Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Human Rotavirus Vaccine Revenue Share by Type (2015-2020)
Table 30. Human Rotavirus Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global Human Rotavirus Vaccine Sales by Application (2015-2020) (K Units)
Table 32. Global Human Rotavirus Vaccine Sales Share by Application (2015-2020)
Table 33. North America Human Rotavirus Vaccine Sales by Country (2015-2020) (K Units)
Table 34. North America Human Rotavirus Vaccine Sales Market Share by Country (2015-2020)
Table 35. North America Human Rotavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Human Rotavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 37. North America Human Rotavirus Vaccine Sales by Type (2015-2020) (K Units)
Table 38. North America Human Rotavirus Vaccine Sales Market Share by Type (2015-2020)
Table 39. North America Human Rotavirus Vaccine Sales by Application (2015-2020) (K Units)
Table 40. North America Human Rotavirus Vaccine Sales Market Share by Application (2015-2020)
Table 41. Europe Human Rotavirus Vaccine Sales by Country (2015-2020) (K Units)
Table 42. Europe Human Rotavirus Vaccine Sales Market Share by Country (2015-2020)
Table 43. Europe Human Rotavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Human Rotavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 45. Europe Human Rotavirus Vaccine Sales by Type (2015-2020) (K Units)
Table 46. Europe Human Rotavirus Vaccine Sales Market Share by Type (2015-2020)
Table 47. Europe Human Rotavirus Vaccine Sales by Application (2015-2020) (K Units)
Table 48. Europe Human Rotavirus Vaccine Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Human Rotavirus Vaccine Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific Human Rotavirus Vaccine Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Human Rotavirus Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Human Rotavirus Vaccine Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Human Rotavirus Vaccine Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific Human Rotavirus Vaccine Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Human Rotavirus Vaccine Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific Human Rotavirus Vaccine Sales Market Share by Application (2015-2020)
Table 57. Latin America Human Rotavirus Vaccine Sales by Country (2015-2020) (K Units)
Table 58. Latin America Human Rotavirus Vaccine Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Human Rotavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Human Rotavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 61. Latin America Human Rotavirus Vaccine Sales by Type (2015-2020) (K Units)
Table 62. Latin America Human Rotavirus Vaccine Sales Market Share by Type (2015-2020)
Table 63. Latin America Human Rotavirus Vaccine Sales by Application (2015-2020) (K Units)
Table 64. Latin America Human Rotavirus Vaccine Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Human Rotavirus Vaccine Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Human Rotavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Human Rotavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Human Rotavirus Vaccine Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Human Rotavirus Vaccine Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Application (2015-2020)
Table 73. Bharat Biotech Corporation Information
Table 74. Bharat Biotech Description and Major Businesses
Table 75. Bharat Biotech Human Rotavirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Bharat Biotech Product
Table 77. Bharat Biotech Recent Development
Table 78. Merck Corporation Information
Table 79. Merck Description and Major Businesses
Table 80. Merck Human Rotavirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Merck Product
Table 82. Merck Recent Development
Table 83. GlaxoSmithKline Corporation Information
Table 84. GlaxoSmithKline Description and Major Businesses
Table 85. GlaxoSmithKline Human Rotavirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. GlaxoSmithKline Product
Table 87. GlaxoSmithKline Recent Development
Table 88. Global Human Rotavirus Vaccine Sales Forecast by Regions (2021-2026) (K Units)
Table 89. Global Human Rotavirus Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 90. Global Human Rotavirus Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 91. Global Human Rotavirus Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 92. North America: Human Rotavirus Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 93. North America: Human Rotavirus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 94. Europe: Human Rotavirus Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 95. Europe: Human Rotavirus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 96. Asia Pacific: Human Rotavirus Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 97. Asia Pacific: Human Rotavirus Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 98. Latin America: Human Rotavirus Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 99. Latin America: Human Rotavirus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Middle East and Africa: Human Rotavirus Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 101. Middle East and Africa: Human Rotavirus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 103. Key Challenges
Table 104. Market Risks
Table 105. Main Points Interviewed from Key Human Rotavirus Vaccine Players
Table 106. Human Rotavirus Vaccine Customers List
Table 107. Human Rotavirus Vaccine Distributors List
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Rotavirus Vaccine Product Picture
Figure 2. Global Human Rotavirus Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Rotarix Product Picture
Figure 4. RotaTeq Product Picture
Figure 5. Rotavac Product Picture
Figure 6. Rotavin-M1 Product Picture
Figure 7. Lanzhou lamb Product Picture
Figure 8. Others Product Picture
Figure 9. Global Human Rotavirus Vaccine Sales Market Share by Application in 2020 & 2026
Figure 10. Hospitals & Clinics
Figure 11. Academic And Research
Figure 12. Others
Figure 13. Human Rotavirus Vaccine Report Years Considered
Figure 14. Global Human Rotavirus Vaccine Market Size 2015-2026 (US$ Million)
Figure 15. Global Human Rotavirus Vaccine Sales 2015-2026 (K Units)
Figure 16. Global Human Rotavirus Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Human Rotavirus Vaccine Sales Market Share by Region (2015-2020)
Figure 18. Global Human Rotavirus Vaccine Sales Market Share by Region in 2019
Figure 19. Global Human Rotavirus Vaccine Revenue Market Share by Region (2015-2020)
Figure 20. Global Human Rotavirus Vaccine Revenue Market Share by Region in 2019
Figure 21. Global Human Rotavirus Vaccine Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Human Rotavirus Vaccine Revenue in 2019
Figure 23. Human Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Human Rotavirus Vaccine Sales Market Share by Type (2015-2020)
Figure 25. Global Human Rotavirus Vaccine Sales Market Share by Type in 2019
Figure 26. Global Human Rotavirus Vaccine Revenue Market Share by Type (2015-2020)
Figure 27. Global Human Rotavirus Vaccine Revenue Market Share by Type in 2019
Figure 28. Global Human Rotavirus Vaccine Market Share by Price Range (2015-2020)
Figure 29. Global Human Rotavirus Vaccine Sales Market Share by Application (2015-2020)
Figure 30. Global Human Rotavirus Vaccine Sales Market Share by Application in 2019
Figure 31. Global Human Rotavirus Vaccine Revenue Market Share by Application (2015-2020)
Figure 32. Global Human Rotavirus Vaccine Revenue Market Share by Application in 2019
Figure 33. North America Human Rotavirus Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 34. North America Human Rotavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Human Rotavirus Vaccine Sales Market Share by Country in 2019
Figure 36. North America Human Rotavirus Vaccine Revenue Market Share by Country in 2019
Figure 37. U.S. Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 38. U.S. Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 40. Canada Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Human Rotavirus Vaccine Market Share by Type in 2019
Figure 42. North America Human Rotavirus Vaccine Market Share by Application in 2019
Figure 43. Europe Human Rotavirus Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 44. Europe Human Rotavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Human Rotavirus Vaccine Sales Market Share by Country in 2019
Figure 46. Europe Human Rotavirus Vaccine Revenue Market Share by Country in 2019
Figure 47. Germany Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 48. Germany Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 50. France Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.K. Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 54. Italy Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 56. Russia Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Human Rotavirus Vaccine Market Share by Type in 2019
Figure 58. Europe Human Rotavirus Vaccine Market Share by Application in 2019
Figure 59. Asia Pacific Human Rotavirus Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Human Rotavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Human Rotavirus Vaccine Sales Market Share by Region in 2019
Figure 62. Asia Pacific Human Rotavirus Vaccine Revenue Market Share by Region in 2019
Figure 63. China Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Human Rotavirus Vaccine Market Share by Type in 2019
Figure 86. Asia Pacific Human Rotavirus Vaccine Market Share by Application in 2019
Figure 87. Latin America Human Rotavirus Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Human Rotavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Human Rotavirus Vaccine Sales Market Share by Country in 2019
Figure 90. Latin America Human Rotavirus Vaccine Revenue Market Share by Country in 2019
Figure 91. Mexico Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Human Rotavirus Vaccine Market Share by Type in 2019
Figure 98. Latin America Human Rotavirus Vaccine Market Share by Application in 2019
Figure 99. Middle East and Africa Human Rotavirus Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa Human Rotavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Human Rotavirus Vaccine Revenue Market Share by Country in 2019
Figure 103. Turkey Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Human Rotavirus Vaccine Market Share by Type in 2019
Figure 110. Middle East and Africa Human Rotavirus Vaccine Market Share by Application in 2019
Figure 111. North America Human Rotavirus Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. North America Human Rotavirus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Human Rotavirus Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Europe Human Rotavirus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Human Rotavirus Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Asia Pacific Human Rotavirus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Human Rotavirus Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Latin America Human Rotavirus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Human Rotavirus Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Middle East and Africa Human Rotavirus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
ヒト狂犬病ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Human Rabies Vaccine Market The global Human Rabies Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Rabies Vaccine Scope and Market Size Human Rabies Vaccine market is…- ヒトパピローマウイルスワクチンの世界市場（～2026年） Human papilloma virus (HPV) vaccine is a vaccine that prevents infection by certain types of human papillomavirus. Market Analysis and Insights: Global Human Papillomavirus Vaccine Market The global Human Papillomavirus Vaccine market size is projected to reach US$ 2220.7 million by 2026, from US$ 2…
- ロタウイルス感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Rotavirus Infections Drug Market The global Rotavirus Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rotavirus Infections Drug Scope and Market Size Rotavirus Infec…
- 経口ワクチンの世界市場（～2026年） Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery …
- ヒトパピローマウイルス（HPV）ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Human Papillomavirus (HPV) Vaccines Market The global Human Papillomavirus (HPV) Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Papillomavirus (HPV) Vaccines Scope a…